Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5445 Journals
4171 Congresses
9600+ Unique Records

NEJM Evidence


Title Abbreviation
NEJM Evid
Electronic ISSN
2766-5526
Readership
Clinicians, Epidemiologists, Outcomes Manager, Physicians, Physicians - Medicine, Researchers, Scientists
Scope
The volume of clinical research continues to grow, yet the standards to establish and validate claims, especially as related to clinical practice, have not followed suit. NEJM Evidence expands the corpus of published research with a focus on providing more context and critical evaluation of the methods and results to support clinical decision-making and does so in a way that respects the time and commitment of the practitioner. NEJM Evidence seeks to advance clinical trial research and clinical practice by: Publishing high-quality studies from the front lines of medical research. Challenging the medical community to take new approaches to clinical trial design and execution that yield more powerful clinical evidence. Sparking debate and conversation around areas of medicine where clinical decisions are made without sufficient evidence. Engaging physicians in a more sophisticated and meaningful way with clinical evidence. Adhering to the rigorous peer-review and quality standards expected from NEJM Group, NEJM Evidence publishes: Original research, clinical trials, and other clinically grounded work (e.g., epidemiology studies, first-in-human trials, meta-analyses) that validate or challenge prior clinical findings. Standard reviews, systematic reviews, and other review types that contextualize research findings with the aim of accelerating clinical adoption of new evidence. Case studies and reviews of clinical trial methodology that enhance understanding of trial strengths and weaknesses. Curbside consult series that addresses common patient care issues. Morning Report series solicited case presentation articles that are delivered in a morning report format. Unique content and features include: Tomorrow’s Trial, a series of short pieces that highlight accepted practices lacking solid evidence and inviting clinician readers to propose clinical trials to fill those gaps. Patient Platform, in which patients who have been in a clinical trial, part of a research study, or had their care impacted strongly by these, share their thoughts on their experience. Stats, STAT!, a brief animated video explaining a statistical concept based on a statistical review.
Sponsoring Association(s)
Massachusetts Medical Society (MMS)
Publisher Name
Massachusetts Medical Society
To see more details about NEJM Evidence, Subscribe Now!
Frequency Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
 
– Kait G
Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
– Michael K.
Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
- Weill Cornell Medical Library